Torkzaban, A
GLP-1 receptor agonists lower the risk of heart failure hospitalization in patients without prior heart failure
se describen aqu solo como observacin de contexto, no como mecanismo establecido
GLP-1 medication use has exploded in recent years
EllieMD is not responsible for the accuracy or completeness of the content shared by guests.EllieMD does not endorse or assume liability for any statements, claims, or representations made by guests during interviews that may cause harm, damage, or inconvenience to viewers
Additionally, sustained weight loss through treatments like tirzepatide can lead to decreased blood pressure and improved cholesterol levels, significantly reducing cardiovascular risks, including heart attack, stroke, and peripheral artery disease